The Latest Breaking News from Insurance

The healthcare sector is set for robust growth, driven by surging demand for quality treatments, a growing patient base, breakthroughs in biopharma, and supportive policies. Therefore, investors could consider undervalued pharmaceutical stocks like Merck & Co. (MRK), Pfizer (PFE), and Cigna (CI) with significant upside potential. Read more.

Given the insurance companies’ essential role in providing financial protection to our daily lives, one could consider investing in companies like Prudential Financial (PRU), CNA Financial Corp. (CNA), and Lincoln National Corp. (LNC), with high-dividend-yields. These stocks could help investors hedge inflationary pressures by generating a steady income stream. Read…

There were only three UK circuit racing events last weekend, but there are still plenty of Ryan Motorsport Insurance Autosport National Rankings changes, with Jason Smyth the highest-placed improver.

It comes down to sky-high homeowners association fees and insurance costs, according to an analysis from Redfin.

The details matter—especially since many older Americans aren’t getting enough exercise, per the CDC.

Summary Aflac (AFL) shows strong technical indicators with 100% buy signals, a 47.77% gain in the last year, and a Trend Seeker buy signal. The company operates through Aflac Japan and Aflac U.S., offering various supplemental health and life insurance products. Fundamental factors include a market cap of $61.98 billion,...

London insurance marketplace’s exposure to Baltimore bridge disaster put at £500 million

Here's an example of what life insurance coverage would look like, with actual dollar amounts, for a hypothetical family with a mortgage and student debt.

Alaska Governor vetoed bipartisan bill mandating insurance coverage for year's supply of birth control, sparking debate.

Alaska Gov. Mike Dunleavy has vetoed a bill to expand birth control access, while a judge struck down decades-old restrictions on who could perform abortions in the state

Marsh & McLennan Companies has underperformed the financial sector over the past year, and analysts remain cautious about the stock’s prospects.